LysoPE(0:0/20:5(5Z,8Z,11Z,14Z,17Z))
|
Basic information |
| Metabolite name | LysoPE(0:0/20:5(5Z,8Z,11Z,14Z,17Z)) |
 | HMDB0011489 |
 |
N/A |
 |
53480938 |
| Synonyms | NA |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | LysoPE(0:0/20:5(5Z,8Z,11Z,14Z,17Z)) |
| HMDB0011489 |
|
N/A |
|
53480938 |
| Synonyms | NA |
| No. of studies | 3 |
|
Relationship between LysoPE(0:0/20:5(5Z,8Z,11Z,14Z,17Z)) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Down |
| Study M609 | Type1 | LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M918 | Type1 | methamphetamine group vs. control group | Serum | C57BL/6 mouse | Up |